Interview with Dr. Tim Oldham, CEO of AdAlta

May 7, 2020

1AD, AdAlta, video

We spoke with AdAlta CEO Dr. Tim Oldham about the company’s I-body platform and the upcoming clinical trial of its lead candidate in Idiopathic Pulmonary Fibrosis.